Cite
HARVARD Citation
Morganti, A. et al. (2016). Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study. Future oncology. pp. 779-787. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morganti, A. et al. (2016). Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study. Future oncology. pp. 779-787. [Online].